Low-density lipoprotein apheresis using the liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy

Journal of Clinical Apheresis

Volumn 11, Issue 3, 1996, Pages 128-131

  Gordon, Bruce R ^a   Saal, Stuart D ^a  

^a ROGOSIN INSTITUTE   (United States)

Author keywords

coronary artery disease; extracorporeal; familial hypercholesterolemia; LDL cholesterol

Indexed keywords

APOLIPOPROTEIN B; CELLULOSE; DEXTRAN SULFATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APHERESIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE COURSE; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MAJOR CLINICAL STUDY; PLASMA VOLUME; PRACTICE GUIDELINE; VASCULAR ACCESS; XANTHOMATOSIS;

BLOOD COMPONENT REMOVAL; CELLULOSE; DEXTRAN SULFATE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; PLASMAPHERESIS;

EID: 0029834416     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1996)11:3<128::AID-JCA2>3.0.CO;2-D     Document Type: Conference Paper

References (23)

1. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 264:3007-3012, 1990.
2. Grossman M, Rader DJ, Muller DWM, Kolansky DM, Kozarsky K, Clark BJ III, Stein EA, Lupien PJ, Brewer HB, Jr, Raper SE, Wilson JM: A pilot study of ex-vivo gene therapy for homozygous familial hypercholesterolemia. Nature Med 1:1148-1154, 1995.
3. Buchwald H: Surgical operation to lower circulating cholesterol. Circulation 28:649, 1963.
4. Stein EA, Mieny C, Spitz L, Sadron I, Pettifor J, Heimann KW, Bersohn I, Dinner M: Portacaval shunt in four patients with homozygous hypercholesterolemia. Lancet 1:832-835, 1975.
5. Bilheimer DW, Grundy SM, Starzl TE, Brown MS: Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 311:1658-1664, 1984.
6. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1:1208-1211, 1975.
7. Schuff-Werner P, Armstrong VW, Eisenhauer TH, Thiery J, Seidel D: Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Contrib Infus Ther 23:118-126, 1988.
8. Lupien PJ, Moorjani S, Awad J: A new approach to the management of familial hypercholesterolemia: removal of plasma cholesterol based on the principle of affinity chromatography. Lancet 1:1261-1264, 1976.
9. Stoffel W, Borberg H, Greve V: Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 2:1005-1007, 1981.
10. Yokoyama S, Hayashi R, Satani M, Yamamoto A: Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 5:613-622, 1985.
11. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M: A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68:19-25, 1987.
12. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993.
13. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM Jr, Illingworth H, Jones PH, Leitman SF, Prihoda JS, Stein EA, Stern TN, Zavoral JH, Zwiener RJ, for the Liposorber Study Group: Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 70:1010-1016, 1992.
14. Schuff-Werner P, Gohlke H, Bartmann U, Corti MC, Dinsenbacher A, Eisenhauer T, Grutzmacher P, Keller C, Kettner U, Kleophas W, Koster W, Olbricht CJ, Richter WO, Seidel D and the HELP-Study Group: The HELP-LDL Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 24:724-732, 1994.
15. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Hishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y: Regression of coronary atherosclerosis by combined-LDL apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 95:1-13, 1992.
16. Borberg H, Oette K: Experience with and conclusions from three different trials on low density lipoprotein apheresis. In Agishi T, Kawamura A, Mineshima M (eds): "Therapeutic plasmapheresis (XII)." Utrecht VSP, 1993, pp 13-20.
17. Thompson GR, Maher VM, Mathews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, et al.: The familial hypercholesterolaemia regression study: a randomised trial of low-density-lipoprotein apheresis. Lancet 345:811-816, 1995.
18. McNamara DJ, Ahrens EF, Jr, Kolb R, Brown CD, Parker TS, Davidson NO, Samuel P, McVie RM: Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool size. Proc. Natl. Acad. Sci. U.S.A. 80:564-568, 1983.
19. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edminston WA, Smink RD, Jr, Sawin HS, Jr, Campos CT, Hansen BJ, Tuna N, Kamegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC, POSCH Group: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 323:946-955, 1990.
20. Daida H, Lee YJ, Yokoi H, Kanoh T, Ishiwata S, Kato K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y, et al.: TI Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group. Am J Cardiol. 73:1037-1040, 1994.
21. Kito Y, Takahashi J, Endo M, Agishi T, Kitamura S, Matsuda H, Fujiwara T, Dohi T, Ito T, Kawashima Y: The effect of LDL-apheresis on the long-term prognosis of hypercholesterolemic patients with coronary artery bypass grafts: a multicenter study. Kyobugeka (Jpn J Thorac Surg) 46:399-404, 1993.
22. Agishi T, Naganuma S, Nakasato S, Kitajima K, Ota K, Ban K, Nomura M: Treatment of atherosclerotic obstruction by LDL adsorption. Angiology 44:222-227, 1993.
23. Tojo K, Sakai S, Miyahara T: Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Jpn J Nephrol 30:91-98, 1988.